Scholarly Index
Paul Anantharajah Tambyah
National University Hospital; 20,420 total citations; 461 total publications; best world rank #84
National University Hospital
20,420Total citations
461Total publications
71H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 189 | SG 8 | 99.04 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 231 | SG 8 | 99.06 |
| Urinary Tract Infections Management | Lifetime | 84 | SG 2 | 99.24 |
| COVID-19 epidemiological studies | Lifetime | 236 | SG 5 | 98.14 |
| Antibiotic Use and Resistance | Lifetime | 191 | SG 4 | 98.64 |
| Antibiotic Resistance in Bacteria | Lifetime | 466 | SG 5 | 98.56 |
| Long-Term Effects of COVID-19 | Lifetime | 788 | SG 8 | 95.00 |
| Influenza Virus Research Studies | Lifetime | 830 | SG 5 | 96.69 |
| Nosocomial Infections in ICU | Lifetime | 340 | SG 3 | 96.87 |
| COVID-19 Impact on Reproduction | Lifetime | 852 | SG 3 | 87.08 |
| Infection Control in Healthcare | Lifetime | 750 | SG 6 | 83.50 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 966 | SG 5 | 82.54 |
| COVID-19 Clinical Research Studies | 2021-2025 | 869 | SG 13 | 96.43 |
| Long-Term Effects of COVID-19 | 2021-2025 | 913 | SG 8 | 93.35 |
| COVID-19 Impact on Reproduction | 2021-2025 | 396 | SG 1 | 89.31 |
| Urinary Tract Infections Management | 2021-2025 | 791 | SG 5 | 77.72 |
| Dermatological and COVID-19 studies | 2021-2025 | 263 | SG 1 | 71.71 |